Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

1.

MRI-based liver iron content predicts for nonrelapse mortality in MDS and AML patients undergoing allogeneic stem cell transplantation.

Wermke M, Schmidt A, Middeke JM, Sockel K, von Bonin M, Schönefeldt C, Mair S, Plodeck V, Laniado M, Weiss G, Schetelig J, Ehninger G, Theurl I, Bornhäuser M, Platzbecker U.

Clin Cancer Res. 2012 Dec 1;18(23):6460-8. doi: 10.1158/1078-0432.CCR-12-1683. Epub 2012 Sep 18.

PMID:
22991415
[PubMed - indexed for MEDLINE]
Free Article
2.

Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation.

Armand P, Kim HT, Rhodes J, Sainvil MM, Cutler C, Ho VT, Koreth J, Alyea EP, Hearsey D, Neufeld EJ, Fleming MD, Steen H, Anderson D, Kwong RY, Soiffer RJ, Antin JH.

Biol Blood Marrow Transplant. 2011 Jun;17(6):852-60. doi: 10.1016/j.bbmt.2010.09.006. Epub 2010 Sep 18.

PMID:
20854920
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.

Busca A, Falda M, Manzini P, D'Antico S, Valfrè A, Locatelli F, Calabrese R, Chiappella A, D'Ardia S, Longo F, Piga A.

Biol Blood Marrow Transplant. 2010 Jan;16(1):115-22. doi: 10.1016/j.bbmt.2009.09.011. Epub 2009 Sep 18.

PMID:
19766730
[PubMed - indexed for MEDLINE]
4.

Association of iron overload with allogeneic hematopoietic cell transplantation outcomes: a prospective cohort study using R2-MRI-measured liver iron content.

Trottier BJ, Burns LJ, DeFor TE, Cooley S, Majhail NS.

Blood. 2013 Aug 29;122(9):1678-84. doi: 10.1182/blood-2013-04-499772. Epub 2013 Jun 18.

PMID:
23777771
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study.

Alessandrino EP, Della Porta MG, Bacigalupo A, Malcovati L, Angelucci E, Van Lint MT, Falda M, Onida F, Bernardi M, Guidi S, Lucarelli B, Rambaldi A, Cerretti R, Marenco P, Pioltelli P, Pascutto C, Oneto R, Pirolini L, Fanin R, Bosi A.

Haematologica. 2010 Mar;95(3):476-84. doi: 10.3324/haematol.2009.011429. Epub 2009 Nov 10.

PMID:
19903678
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Marrow fibrosis as a risk factor for posttransplantation outcome in patients with advanced myelodysplastic syndrome or acute myeloid leukemia with multilineage dysplasia.

Scott BL, Storer BE, Greene JE, Hackman RC, Appelbaum FR, Deeg HJ.

Biol Blood Marrow Transplant. 2007 Mar;13(3):345-54.

PMID:
17317588
[PubMed - indexed for MEDLINE]
7.

Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.

Valcárcel D, Martino R, Caballero D, Martin J, Ferra C, Nieto JB, Sampol A, Bernal MT, Piñana JL, Vazquez L, Ribera JM, Besalduch J, Moraleda JM, Carrera D, Brunet MS, Perez-Simón JA, Sierra J.

J Clin Oncol. 2008 Feb 1;26(4):577-84. Epub 2007 Dec 17.

PMID:
18086801
[PubMed - indexed for MEDLINE]
Free Article
8.

Serum ferritin and disease status at transplantation predict the outcome of allo-SCT in patients with AML or myelodysplastic syndrome.

Tachibana T, Takasaki H, Tanaka M, Maruta A, Hyo R, Ishigatsubo Y, Kanamori H.

Bone Marrow Transplant. 2011 Jan;46(1):150-1. doi: 10.1038/bmt.2010.62. Epub 2010 Apr 12. No abstract available.

PMID:
20383206
[PubMed - indexed for MEDLINE]
9.

Prognostic impact of pretransplant iron overload measured with magnetic resonance imaging on severe infections in allogeneic stem cell transplantation.

Virtanen JM, Itälä-Remes MA, Remes KJ, Vahlberg T, Saunavaara JP, Sinisalo M, Parkkola RK.

Eur J Haematol. 2013 Jul;91(1):85-93. doi: 10.1111/ejh.12123. Epub 2013 May 31.

PMID:
23586843
[PubMed - indexed for MEDLINE]
10.

Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML.

Nevill TJ, Hogge DE, Toze CL, Nantel SH, Power MM, Abou Mourad YR, Song KW, Lavoie JC, Forrest DL, Barnett MJ, Shepherd JD, Nitta JY, Wong S, Sutherland HJ, Smith CA.

Bone Marrow Transplant. 2008 Nov;42(10):659-66. doi: 10.1038/bmt.2008.226. Epub 2008 Aug 4.

PMID:
18679372
[PubMed - indexed for MEDLINE]
11.

Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation.

Lim ZY, Fiaccadori V, Gandhi S, Hayden J, Kenyon M, Ireland R, Marsh J, Ho AY, Mufti GJ, Pagliuca A.

Leuk Res. 2010 Jun;34(6):723-7. doi: 10.1016/j.leukres.2009.10.028. Epub 2009 Nov 26.

PMID:
19944463
[PubMed - indexed for MEDLINE]
12.

Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes.

Kebriaei P, Kline J, Stock W, Kasza K, Le Beau MM, Larson RA, van Besien K.

Bone Marrow Transplant. 2005 May;35(10):965-70.

PMID:
15806131
[PubMed - indexed for MEDLINE]
13.

High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors.

Majhail NS, DeFor T, Lazarus HM, Burns LJ.

Biol Blood Marrow Transplant. 2008 Jul;14(7):790-4. doi: 10.1016/j.bbmt.2008.04.009.

PMID:
18541198
[PubMed - indexed for MEDLINE]
14.

Does iron overload really matter in stem cell transplantation?

Armand P, Sainvil MM, Kim HT, Rhodes J, Cutler C, Ho VT, Koreth J, Alyea EP, Neufeld EJ, Kwong RY, Soiffer RJ, Antin JH.

Am J Hematol. 2012 Jun;87(6):569-72. doi: 10.1002/ajh.23188. Epub 2012 Apr 4.

PMID:
22473510
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Assessing iron overload: are we there yet?

Kruger PC, Leahy MF, Olynyk JK.

Clin Cancer Res. 2012 Dec 1;18(23):6395-7. doi: 10.1158/1078-0432.CCR-12-2881. Epub 2012 Oct 10.

PMID:
23052256
[PubMed - indexed for MEDLINE]
Free Article
16.

Severe hypoalbuminemia at day 90 predicts worse nonrelapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome.

Kharfan-Dabaja MA, Chavez JC, Yu D, Zhu W, Fernandez-Vertiz EI, Perkins J, Shapiro J, Bookout R, Perez L, Fernandez HF, Komrokji RS, Lancet J, Brand L, Field T, Ayala E, Janssen W, List AF, Anasetti C.

Biol Blood Marrow Transplant. 2011 Mar;17(3):384-93. doi: 10.1016/j.bbmt.2010.07.011. Epub 2010 Jul 22.

PMID:
20655389
[PubMed - indexed for MEDLINE]
17.

Optimizing therapy for iron overload in the myelodysplastic syndromes: recent developments.

Leitch HA.

Drugs. 2011 Jan 22;71(2):155-77. doi: 10.2165/11585280-000000000-00000. Review.

PMID:
21275444
[PubMed - indexed for MEDLINE]
18.

A prospective study of iron overload management in allogeneic hematopoietic cell transplantation survivors.

Majhail NS, Lazarus HM, Burns LJ.

Biol Blood Marrow Transplant. 2010 Jun;16(6):832-7. doi: 10.1016/j.bbmt.2010.01.004. Epub 2010 Jan 14.

PMID:
20079863
[PubMed - indexed for MEDLINE]
19.

Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies.

Tachibana T, Tanaka M, Takasaki H, Numata A, Ito S, Watanabe R, Hyo R, Ohshima R, Hagihara M, Sakai R, Fujisawa S, Tomita N, Fujita H, Maruta A, Ishigatsubo Y, Kanamori H.

Int J Hematol. 2011 Mar;93(3):368-74. doi: 10.1007/s12185-011-0784-0. Epub 2011 Feb 18.

PMID:
21331523
[PubMed - indexed for MEDLINE]
20.

Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation.

Kröger N, Brand R, van Biezen A, Zander A, Dierlamm J, Niederwieser D, Devergie A, Ruutu T, Cornish J, Ljungman P, Gratwohl A, Cordonnier C, Beelen D, Deconinck E, Symeonidis A, de Witte T; Myelodysplastic Syndromes Subcommittee of The Chronic Leukaemia Working Party of European Group for Blood and Marrow Transplantation (EBMT).

Haematologica. 2009 Apr;94(4):542-9. doi: 10.3324/haematol.2008.000927. Epub 2009 Mar 10.

PMID:
19278968
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk